Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05705544 · ClinicalTrials.gov registry record · NA
Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 447
- Enrollment target
NCT05705544 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 447 participants.
The verdict
NCT05705544, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 447 participants
- Enrollment target
Study Summary
This is an investigator-initiated, cluster randomized controlled trial. The primary objective is to compare the diagnostic yield of the Ion™ Endoluminal System (SSCB) to the ILLUMISITE™ Platform (EMN bronchoscopy) in patients undergoing bronchoscopy for peripheral pulmonary lesion (PPL) evaluation.
Interventions
- DEVICE ILLUMISITE™ Platform (EMN bronchoscopy)
- DEVICE Ion™ Endoluminal System (SSCB bronchoscopy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 447 participants |
| Start Date | 2023-03-06 |
| Est. Completion | 2024-04-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05705544
The ClinicalTrials.gov registry entry for NCT05705544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 447 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ILLUMISITE™ Platform (EMN bronchoscopy) is the first listed.
NCT05705544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05705544 about?
NCT05705544 is a clinical study titled "Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)". This is an investigator-initiated, cluster randomized controlled trial. The primary objective is to compare the diagnostic yield of the Ion™ Endoluminal System (SSCB) to the ILLUMISITE™ Platform (EMN bronchoscopy) in patients undergoing bronchoscopy for peripheral pulmonary lesion (PPL) evaluation.
What is the current status of trial NCT05705544?
This trial is currently completed. It is a NA study. The enrollment target is 447 participants. The study started on 2023-03-06. Estimated completion is 2024-04-09.
What interventions are being tested in trial NCT05705544?
The interventions under investigation include: ILLUMISITE™ Platform (EMN bronchoscopy) (DEVICE), Ion™ Endoluminal System (SSCB bronchoscopy) (DEVICE).
Who is sponsoring clinical trial NCT05705544?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.